The shape of Smith & Nephew 2006
Revenue
Total group turnover in 2006 was $2.8 bllion. the current business breakdown of sales is :

| Orthopaedic Reconstruction | 33% | $919m + 10% | Hip, knee and shoulder products |
| Orthopaedic Trauma & Clinical Therapies |
18% | $497m + 13% | Fixation products for broken bones, joint fluid therapy products, low frequency ultrasound devices that accelerate bone healing |
| Endoscopy | 24% | $665m + 9% | Products for minimally invasive surgery |
| Advanced Wound Management | 25% | $698m + 1% | Advanced treatments for hard to heal wounds |
Close to customers and patients
To help patients regain their lives more quickly and fully, we work with healthcare professionals on emerging new technologies and techniques. Our world-class, specialised salesforce provides frontline support to our customers -and enables us to gain greater understanding of their needs. This commitment is underpinned by a unique range of education and training programmes designed specifically for healthcare professionals: in 2006 we helped over 150,000 nurses and clinicians learn new techniques and skills. Strong relationships with healthcare professionals are fundamental to our business. To earn their trust and confidence we know we must always behave with absolute integrity.
Revenues
Total group turnover in 2006 was $2.8 billion. The current geographical breakdown of sales is:
The shape of Smith & Nephew 2006: our markets

| US | 49% | $1,365m + 8% |
| Europe |
31% UK 9% |
$867m + 6% |
| Rest of the world Japan | 20% Japan 5% |
$547m + 12% |
Note: Underlying sales growths.
Smith & Nephew's four Global Business Units - Orthopaedic Reconstruction, Orthopaedic Trauma, Endoscopy and Advanced Wound Management - have worldwide responsibility for the research and development, manufacturing and marketing of their respective product ranges. Together, they offer over 1,000 product ranges